By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Eisai Company, Ltd. 

4-6-10 Koishikawa, Bunkyo-ku

Tokyo    112-8088  Japan
Phone: 81-3-3817-3700 Fax: n/a


SEARCH JOBS


Key Statistics


Email: webmaster@eisai.co.jp
Ownership: Public

Web Site: Eisai Company
Employees: 7,043
Symbol: ESALY.PK
 









Company News
AbbVie (ABBV), Eisai Company (ESALY.PK), And EA Pharma Obtain Additional Approval For New Dosing Regimen Of Fully Human Anti-TNF Monoclonal Antibody Humira In Patients With Crohn's Disease 6/20/2016 9:55:54 AM
Eisai Company (ESALY.PK) Launches New Oral Suspension Formulation For Antiepileptic Drug Fycompa (Perampanel) In The United States 6/16/2016 10:30:33 AM
Eisai Company (ESALY.PK) To Launch In-House Developed Antiepileptic Drug Fycompa (Perampanel Hydrate) 5/25/2016 9:56:37 AM
Eisai Company (ESALY.PK) Beefs Up Neurology Team with Ex-Pfizer (PFE), Sanofi (SNY) Execs 4/22/2016 7:13:18 AM
Eisai Company (ESALY.PK) Release: Aricept Approved In The Philippines For New Indication As Treatment For Dementia With Lewy Bodies 4/14/2016 9:23:12 AM
Dr. Reddy's Laboratories Ltd. (RDY) Inks Licensing Pact with Japan's Eisai Company (ESALY.PK) for Anti-Cancer Agent 3/31/2016 6:08:26 AM
As part of Eisai Company (ESALY.PK)’s Strategic Plan, Morphotek Subsidiary Cuts 27 Jobs as Part of Restructuring 3/23/2016 7:08:03 AM
Eisai Company (ESALY.PK) Buys Cancer Drug Rights From HUYA Bioscience in $280 Million+ Deal 2/1/2016 5:56:38 AM
Eisai Company (ESALY.PK) Pays $78 Million To Acquire Small China Generic Drugmaker 12/2/2015 12:56:12 PM
Eisai Company (ESALY.PK) To Present Latest Clinical Data On Lenvima (Lenvatinib) And Halaven (Eribulin) At European Cancer Congress 9/14/2015 12:09:11 PM
12345678910...
//-->